- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.80 Å
- Oligo State
- hetero-3-2-mer
- Ligands
- 10 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
- 3 x D12: DODECANE(Non-covalent)
D12.5: 4 residues within 4Å:- Chain A: A.457, F.458, R.468, I.472
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:F.458
D12.16: 2 residues within 4Å:- Chain B: W.895
- Ligands: D10.26
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:W.895
D12.31: 3 residues within 4Å:- Chain C: S.523, S.530
- Ligands: LMT.27
No protein-ligand interaction detected (PLIP)- 6 x DDQ: DECYLAMINE-N,N-DIMETHYL-N-OXIDE(Non-covalent)
DDQ.6: 4 residues within 4Å:- Chain A: P.9, W.13, I.17
- Chain B: W.895
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:W.13, A:I.17
DDQ.18: 5 residues within 4Å:- Chain A: F.4, F.11
- Chain B: G.440, G.444, C.887
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:F.11
DDQ.19: 4 residues within 4Å:- Chain B: F.458, F.459, R.468, I.472
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:F.458, B:F.458, B:I.472
DDQ.33: 5 residues within 4Å:- Chain C: F.388, A.457, R.468, S.471
- Ligands: DDQ.35
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:F.388, C:A.457
DDQ.34: 3 residues within 4Å:- Chain C: F.4, F.5
- Ligands: LMT.2
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:F.5
DDQ.35: 4 residues within 4Å:- Chain C: A.457, F.458, R.468
- Ligands: DDQ.33
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:F.458, C:F.458
- 6 x GOL: GLYCEROL(Non-functional Binders)
GOL.7: 4 residues within 4Å:- Chain A: K.55, G.691, H.692, E.693
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:K.55, A:H.692, A:E.693
- Water bridges: A:Q.58
GOL.8: 5 residues within 4Å:- Chain A: A.47, S.48, Q.125, G.126, S.128
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:Q.125, A:S.128, A:S.128
- Water bridges: A:S.46, A:S.48
GOL.9: 7 residues within 4Å:- Chain A: G.51, D.276, G.755, M.774
- Chain C: Q.218, G.221, T.222
6 PLIP interactions:4 interactions with chain A, 2 interactions with chain C- Hydrogen bonds: A:G.51, A:D.276
- Water bridges: A:D.276, A:R.780, C:Q.218, C:T.222
GOL.25: 7 residues within 4Å:- Chain A: R.168, E.309
- Chain B: L.75, M.76, Y.77, M.78, N.820
4 PLIP interactions:2 interactions with chain A, 2 interactions with chain B- Hydrogen bonds: A:R.168, A:E.309, B:L.75, B:M.78
GOL.41: 7 residues within 4Å:- Chain C: R.185, E.273, N.274, G.755, G.756, Y.772, M.774
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:R.185, C:R.185, C:G.756
GOL.44: 4 residues within 4Å:- Chain A: Y.811
- Chain E: E.20, R.23, D.44
3 PLIP interactions:2 interactions with chain E, 1 interactions with chain A- Hydrogen bonds: E:R.23, E:R.23, A:Y.811
- 2 x HEX: HEXANE(Non-covalent)(Non-functional Binders)
- 1 x FUA: FUSIDIC ACID(Non-covalent)
- 2 x PTY: PHOSPHATIDYLETHANOLAMINE(Non-covalent)
PTY.15: 10 residues within 4Å:- Chain B: F.4, R.8, F.11
- Chain C: Q.439, V.443, M.447, A.890, L.891, Y.892, E.947
7 PLIP interactions:3 interactions with chain C, 4 interactions with chain B- Hydrophobic interactions: C:V.443, C:A.890, B:F.4, B:F.11, B:F.11
- Hydrogen bonds: C:Q.439
- Salt bridges: B:R.8
PTY.30: 11 residues within 4Å:- Chain B: W.13
- Chain C: A.878, I.882, F.885, S.894, W.895, S.896, K.950, R.1030, F.1033, S.1034
15 PLIP interactions:2 interactions with chain B, 13 interactions with chain C- Hydrophobic interactions: B:W.13, B:W.13, C:A.878, C:I.882, C:I.882, C:F.885, C:W.895, C:W.895
- Hydrogen bonds: C:W.895, C:S.896, C:S.896, C:K.950, C:K.950
- Salt bridges: C:K.950, C:R.1030
- 1 x DDR: (2S)-3-hydroxypropane-1,2-diyl didecanoate(Non-covalent)
DDR.17: 15 residues within 4Å:- Chain B: V.452, M.456, F.459, Y.467, M.552, F.556, Y.877, S.880, L.881, V.884, V.905, Q.928, L.931, L.932, I.935
12 PLIP interactions:12 interactions with chain B- Hydrophobic interactions: B:F.556, B:Y.877, B:L.881, B:V.884, B:V.905, B:V.905, B:L.931, B:L.932, B:I.935, B:I.935
- Hydrogen bonds: B:Y.467, B:Y.877
- 3 x OCT: N-OCTANE(Non-covalent)
OCT.20: 1 residues within 4Å:- Chain B: F.4
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:F.4
OCT.21: 3 residues within 4Å:- Chain B: Y.527, S.530
- Ligands: LMT.11
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:Y.527
OCT.36: 2 residues within 4Å:- Chain C: M.552, F.556
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:F.556, C:F.556
- 5 x CL: CHLORIDE ION(Non-functional Binders)
CL.22: 2 residues within 4Å:- Chain B: N.361, F.362
Ligand excluded by PLIPCL.37: 2 residues within 4Å:- Chain C: G.691, H.692
Ligand excluded by PLIPCL.38: 3 residues within 4Å:- Chain C: Q.228, Q.229, L.230
Ligand excluded by PLIPCL.39: 2 residues within 4Å:- Chain C: N.231, S.233
Ligand excluded by PLIPCL.40: 5 residues within 4Å:- Chain C: M.575, F.617, R.717, N.719, L.828
Ligand excluded by PLIP- 2 x SO4: SULFATE ION(Non-functional Binders)
SO4.23: 5 residues within 4Å:- Chain B: R.239, N.760, D.761
- Chain C: P.119, Q.120
4 PLIP interactions:2 interactions with chain B, 2 interactions with chain C- Hydrogen bonds: B:D.761, C:Q.120, C:Q.120
- Salt bridges: B:R.239
SO4.24: 3 residues within 4Å:- Chain B: K.55, G.691, H.692
7 PLIP interactions:7 interactions with chain B- Hydrogen bonds: B:H.692
- Water bridges: B:Q.58, B:Q.58, B:L.690, B:G.691, B:E.693
- Salt bridges: B:K.55
- 1 x D10: DECANE(Non-covalent)
- 1 x C14: TETRADECANE(Non-covalent)
- 1 x ETE: 2-{2-[2-2-(METHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tam, H.K. et al., Binding and Transport of Carboxylated Drugs by the Multidrug Transporter AcrB. J.Mol.Biol. (2020)
- Release Date
- 2019-11-13
- Peptides
- Multidrug efflux pump subunit AcrB: ABC
DARPin: DE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.80 Å
- Oligo State
- hetero-3-2-mer
- Ligands
- 10 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
- 3 x D12: DODECANE(Non-covalent)
- 6 x DDQ: DECYLAMINE-N,N-DIMETHYL-N-OXIDE(Non-covalent)
- 6 x GOL: GLYCEROL(Non-functional Binders)
- 2 x HEX: HEXANE(Non-covalent)(Non-functional Binders)
- 1 x FUA: FUSIDIC ACID(Non-covalent)
- 2 x PTY: PHOSPHATIDYLETHANOLAMINE(Non-covalent)
- 1 x DDR: (2S)-3-hydroxypropane-1,2-diyl didecanoate(Non-covalent)
- 3 x OCT: N-OCTANE(Non-covalent)
- 5 x CL: CHLORIDE ION(Non-functional Binders)
- 2 x SO4: SULFATE ION(Non-functional Binders)
- 1 x D10: DECANE(Non-covalent)
- 1 x C14: TETRADECANE(Non-covalent)
- 1 x ETE: 2-{2-[2-2-(METHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tam, H.K. et al., Binding and Transport of Carboxylated Drugs by the Multidrug Transporter AcrB. J.Mol.Biol. (2020)
- Release Date
- 2019-11-13
- Peptides
- Multidrug efflux pump subunit AcrB: ABC
DARPin: DE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.